Inhaled hydrogen sulfide prevents endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice

Antioxidants and Redox Signaling

Volumn 17, Issue 1, 2012, Pages 11-21

  Tokuda, Kentaro ^a   Kida, Kotaro ^a   Marutani, Eizo ^a   Crimi, Ettore ^a   Bougaki, Masahiko ^a   Khatri, Ashok ^a   Kimura, Hideo ^b   Ichinose, Fumito ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CYSTATHIONINE GAMMA LYASE; CYTOKINE; HYDROGEN SULFIDE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; NITRATE; NITRITE; SULFIDE; THIOSULFATE; THIOSULFATE SULFURTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; BREATHING; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTOXEMIA; ENZYME ACTIVATION; ENZYME REGULATION; INFLAMMATION; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; SURVIVAL RATE; UPREGULATION;

ADMINISTRATION, INHALATION; ANIMALS; ANTI-INFLAMMATORY AGENTS; ENDOTOXINS; HYDROGEN SULFIDE; INFLAMMATION; MALE; MICE; MICE, INBRED BALB C; SULFIDES;

MUS;

EID: 84860760510     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4363     Document Type: Article

References (30)

1. Cheng F, Xie S, Guo M, Fang H, Li X, Yin J, Lu G, Li Y, Ji X, and Yu S. Altered glucose metabolism and preserved energy charge and neuronal structures in the brain of mouse intermittently exposed to hypoxia. J Chem Neuroanat 42: 65-71, 2011.
2. Doeller JE, Isbell TS, Benavides G, Koenitzer J, Patel H, Patel RP, Lancaster JR, Jr., Darley-Usmar VM, and Kraus DW. Polarographic measurement of hydrogen sulfide production and consumption by mammalian tissues. Anal Biochem 341: 40-51, 2005.
3. Ebong S,Call D, Nemzek J, Bolgos G, NewcombD, and Remick D. Immunopathologic alterations in murine models of sepsis of increasing severity. Infect and Immun 67: 6603-6610, 1999.
4. Hayden MR and Goldsmith DJA. Sodium thiosulfate: New hope for the treatment of calciphylaxis. Semin Dial 23: 258-262, 2010.
5. Hellman J, Roberts JD, Jr., Tehan MM, Allaire JE, and Warren HS. Bacterial peptidoglycan-associated lipoprotein is released into the bloodstream in gram-negative sepsis and causes inflammation and death in mice. J Biol Chem 277: 14274-14280, 2002.
6. Hildebrandt TM and Grieshaber MK. Three enzymatic activities catalyze the oxidation of sulfide to thiosulfate in mammalian and invertebrate mitochondria. FEBS J 275: 3352-3361, 2008.
7. Ishii I, Akahoshi N, Yu XN, Kobayashi Y, Namekata K, Komaki G, and Kimura H. Murine cystathionine gammalyase: Complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression. Biochem J 381: 113-123, 2004.
8. Kabil O and Banerjee R. Redox biochemistry of hydrogen sulfide. J Biol Chem 285: 21903-21907, 2010.
9. Kashiba M, Kajimura M, Goda N, and Suematsu M. From O2 to H2S: A landscape view of gas biology. Keio J Med 51: 1-10, 2002.
10. L'Her E, Amerand A, Vettier A, and Sebert P. Effects of mild induced hypothermia during experimental sepsis. Crit Care Med 34: 2621-2623, 2006.
11. Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, Wang ZJ, Anuar FB, Whiteman M, Salto-Tellez M, and Moore PK. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 19: 1196-1198, 2005.
12. Li L, Rossoni G, Sparatore A, Lee LC, Del Soldato P, and Moore PK. Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic Biol Med 42: 706-719, 2007.
13. Li L, Salto-Tellez M, Tan CH, Whiteman M, and Moore PK. GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat. Free Radic Biol Med 47: 103-113, 2009.
14. Li L, Whiteman M, Guan YY, Neo KL, Cheng Y, Lee SW, Zhao Y, Baskar R, Tan CH, and Moore PK. Characterization of a novel, water-soluble hydrogen sulfide releasing molecule (GYY4137). Circulation 117: 2351-2360, 2008.
15. Mikami Y, Shibuya N, Kimura Y, Nagahara N, Ogasawara Y, and Kimura H. Thioredoxin and dihydrolipoic acid are required for 3-mercaptopyruvate sulfurtransferase to produce hydrogen sulfide. Biochem J 439: 479-485, 2011.
16. Nautiyal KM, McKellar H, Silverman AJ, and Silver R. Mast cells are necessary for the hypothermic response to LPSinduced sepsis. Am J Physiol Regul Integr Comp Physiol 296: R595-R602, 2009.
17. Olson KR. Is hydrogen sulfide a circulating "gasotransmitter" in vertebrate blood? Biochim Biophys Acta 1787: 856-863, 2009.
18. Qing M, Nimmesgern A, Heinrich PC, Schumacher K, Vazquez-Jimenez JF, Hess J, von Bernuth G, and Seghaye MC. Intrahepatic synthesis of tumor necrosis factor-alpha related to cardiac surgery is inhibited by interleukin-10 via the Janus kinase ( Jak)/signal transducers and activator of transcription (STAT) pathway. Crit Care Med 31: 2769-2775, 2003.
19. Remick DG and Xioa H. Hypothermia and sepsis. Front Biosci 11: 1006-1013, 2006.
20. Shen X, Pattillo CB, Pardue S, Bir SC, Wang R, and Kevil CG. Measurement of plasma hydrogen sulfide in vivo and in vitro. Free Rad Biol Med 50: 1021-1031, 2011.
21. Shibuya N, Tanaka M, Yoshida M, Ogasawara Y, Togawa T, Ishii K, and Kimura H. 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal 11: 703-714, 2009.
22. Stipanuk MH and Beck PW. Characterization of the enzymic capacity for cysteine desulfhydration in liver and kidney of the rat. Biochem J 206: 267-277, 1982.
23. Suzuki K, Olah G, Modis K, Coletta C, Kulp G, GeröD, Szoleczky P, Chang T, Zhou Z, Wu L, Wang R, Papapetropoulos A, and Szabo C. Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. PNAS 108: 13829-13834, 2011.
24. Vazquez E, Polo C, Stedile G, Schebor C, Karahanian E, and Batlle A. Isolation and partial purification of mitochondrial and cytosolic rhodanese from liver of normal and p-dimethylaminoazobenzene treated mice. Int J Biochem Cell Biol 27: 523-529, 1995.
25. Volpato GP, Searles R, Yu B, Scherrer-Crosbie M, Bloch KD, Ichinose F, and Zapol WM. Inhaled hydrogen sulfide: A rapidly reversible inhibitor of cardiac and metabolic function in the mouse. Anesthesiology 108: 659-668, 2008.
26. Whiteman M, Li L, Rose P, Tan CH, Parkinson DB, and Moore PK. The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages. Antioxid Redox Signal 12: 1147-1154, 2009.
27. Wintner EA, Deckwerth TL, Langston W, Bengtsson A, Leviten D, Hill P, Insko MA, Dumpit R, VandenEkart E, Toombs CF, and Szabo C. A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood. Br J Pharmacol 160: 941-957, 2010.
28. Xiao H and Remick DG. Correction of perioperative hypothermia decreases experimental sepsis mortality by modulating the inflammatory response. Crit Care Med 33: 161-167, 2005.
29. Zhang H, Moochhala SM, and Bhatia M. Endogenous hydrogen sulfide regulates inflammatory response by activating the ERK pathway in polymicrobial sepsis. J Immunol 181: 4320-4331, 2008.
30. Zhang H, Zhi L, Moochhala S, Moore PK, and Bhatia M. Hydrogen sulfide acts as an inflammatory mediator in cecal ligation and puncture-induced sepsis in mice by upregulating the production of cytokines and chemokines via NF-jB. Am J Physiol Lung Cell Mol Physiol 292: L960-L971, 2007.